Pharma Plus 3 Calendula SRL is a company in Romania, with a head office in AFUMATI. The company operates in the Department Stores sector. It was first established on July 16, 1991. There are currently 15 (2024) people employed by Pharma Plus 3 Calendula SRL. From the latest financial highlights, Pharma Plus 3 Calendula SRL reported a net sales revenue increase of 1.27% in 2024. During that time, Pharma Plus 3 Calendula SRL’s total assets grew by 15.1%. Pharma Plus 3 Calendula SRL’s net profit margin increased by 0.3% in 2024.

Headquarters
Cartierul Br. Novac
AFUMATI; Dolj;

Contact Details: Purchase the Pharma Plus 3 Calendula SRL report to view the information.

Basic Information

Total Employees:

Purchase the Pharma Plus 3 Calendula SRL report to view the information.

Registered Capital:

Purchase the Pharma Plus 3 Calendula SRL report to view the information.

Financial Auditors:

Purchase the Pharma Plus 3 Calendula SRL report to view the information.

Incorporation Date:

July 16, 1991

Key Executives

Purchase this report to view the information.

Administrator

Ownership Details

Purchase this report to view the information.

100%

Company Performance

Financial values in the chart are available after Pharma Plus 3 Calendula SRL report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency RON. Absolute financial data is included in the purchased report.

Net sales revenue

1.27%▲

Total operating revenue

1.32%▲

Operating profit (EBIT)

8.48%▲

EBITDA

4.62%▲

Net Profit (Loss) for the Period

35.48%▲

Total Assets

15.1%▲

Total Equity

3.47%▲

Operating Profit Margin (ROS)

0.11%▲

Net Profit Margin

0.3%▲

Return on Equity (ROE)

0.8%▲

Quick Ratio

-0.05%▼

Cash Ratio

-0.01%▼

Pharma Plus 3 Calendula SRL (Romania)